The information provided by bard represents all of the known information at this time.
Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
The following were reviewed as part of this investigation: patient severity, frequency analysis, applicable previous investigation(s), sample (if available), applicable fmea documents, labeling, and applicable manufacture records.
Based on a review of this information, the following was concluded: the complaint of bleedback through the infusion set was inconclusive due to the sample condition.
One photograph was provided for investigation.
The photo showed one 20g ez huber infusion set being used on a patient.
A dressing was attached to the needle housing.
The extension set tubing between the needle housing and the y-site, and between the y-site and the proximal clamp was full of what appeared to be blood.
The distal clamp appeared to be closed.
The proximal clamp was not fully shown in the photo.
The proximal end of the proximal clamp, the luer adaptor, and connection made at the luer adaptor were not visible in the photo.
Although blood was visible in the extension set tubing, the cause of and the conditions surrounding the reported event were unknown.
Potential contributing factors include the pressure gradient within the infusion set, improper connections, and clamp damage.
The product ifu states, ¿fully tighten all connections, y-site end caps, or needleless connectors before use.
Failure to attach an end cap or appropriate needleless device after removing a male luer locking end cap or needleless connector can result in an embolism or bleeding".
A lot history review (lhr) of recn2786 showed no other similar product complaint(s) from this lot number.
|